Characterization of phenotypic and genotypic traits of carbapenem-resistant Acinetobacter baumannii clinical isolates recovered from a tertiary care hospital in Taif, Saudi Arabia

References

• Rahman A, Iza N, Ismail S, et al. Acinetobacter spp. infections in Malaysia: a review of antimicrobial resistance trends, mechanisms and epidemiology. Front Microbiol. 2017;8:2479. doi:10.3389/fmicb.2017.0247929312188
   PubMed Web of Science ®Google Scholar
• Kim B, Bae W, Kim K, Lee H, Yoon J. Nosocomial infection due to Acinetobacter baumannii in korean ICUs a multicenter study. Crit Care Med. 2018;46(1):343. doi:10.1097/01.ccm.0000528728.54507.7e29337802
   PubMed Web of Science ®Google Scholar
• Almaghrabi MK, Joseph MR, Assiry MM, Hamid ME. Multidrug-resistant Acinetobacter baumannii: an emerging health threat in Aseer Region, Kingdom of Saudi Arabia. Can J Infect Dis Med Microbiol. 2018;2018. doi:10.1155/2018/9182747.
   Web of Science ®Google Scholar
• Majid Bouzari D, Abedini F, Yadegari S. Identification of genomic species of Acinetobacter isolated from burns of ICU patients. Arch Iran Med. 2015;18(10):638–642.26443247
   PubMed Web of Science ®Google Scholar
• Al Atrouni A, Joly-Guillou M-L, Hamze M, Kempf M. Reservoirs of non-baumannii Acinetobacter species. Front Microbiol. 2016;7:49.26870013
   PubMed Web of Science ®Google Scholar
• Wong D, Nielsen TB, Bonomo RA, Pantapalangkoor P, Luna B, Spellberg B. Clinical and pathophysiological overview of Acinetobacter infections: a century of challenges. Clin Microbiol Rev. 2017;30(1):409–447.27974412
   PubMed Web of Science ®Google Scholar
• Turton JF, Woodford N, Glover J, Yarde S, Kaufmann ME, Pitt TL. Identification of Acinetobacter baumannii by detection of the blaOXA-51-like carbapenemase gene intrinsic to this species. J Clin Microbiol. 2006;44(8):2974–2976.16891520
   PubMed Web of Science ®Google Scholar
• Pakharukova N, Tuittila M, Paavilainen S, et al. Structural basis for Acinetobacter baumannii biofilm formation. Proc Natl Acad Sci. 2018;115(21):5558–5563.29735695
   PubMed Web of Science ®Google Scholar
• Ehlers M, Hughes J, Kock M. Prevalence of carbapenemases in Acinetobacter baumannii. In: antibiotic resistant bacteria-a continuous challenge in the new millennium. InTech. 2012:213–246.
   Google Scholar
• Antunes L, Visca P, Towner KJ. Acinetobacter baumannii: evolution of a global pathogen. Pathog Dis. 2014;71(3):292–301. doi:10.1111/2049-632X.1212524376225
   PubMed Web of Science ®Google Scholar
• Manchanda V, Sanchaita S, Singh N. Multidrug resistant Acinetobacter. J Glob Infect Dis. 2010;;2(3):291. doi:10.4103/0974-777X.6853820927292
   PubMedGoogle Scholar
• Ye Y, Xu L, Han Y, Chen Z, Liu C, Ming L. Mechanism for carbapenem resistance of clinical Enterobacteriaceae isolates. Exp Ther Med. 2018;15(1):1143–1149. doi:10.3892/etm.2017.548529399114
   PubMed Web of Science ®Google Scholar
• Quale J, Spelman D, Hooper D, Bloom A. Overview of carbapenemase producing GRam-negative bacilli. UpToDate: Waltham, MA, USA, Accessed On. 2016;21.
   Google Scholar
• Queenan AM, Bush K. Carbapenemases: the versatile β-lactamases. Clin Microbiol Rev. 2007;20(3):440–458. doi:10.1128/CMR.00001-0717630334
   PubMed Web of Science ®Google Scholar
• Meini MR, Llarrull L, Vila A. Evolution of metallo-β-lactamases: trends revealed by natural diversity and in vitro evolution. Antibiotics. 2014;3(3):285–316.25364574
   PubMedGoogle Scholar
• Berrazeg M, Diene S, Medjahed L, et al. New Delhi Metallo-beta-lactamase around the world: an eReview using google maps. Euro Surveill. 2014;19(20):20809. doi:10.2807/1560-7917.ES2014.19.20.2080924871756
   PubMedGoogle Scholar
• Opazo A, Domínguez M, Bello H, Amyes SG, González-Rocha G. OXA-type carbapenemases in Acinetobacter baumannii in South America. J Infect Dev Ctries. 2012;6(04):311–316.22505439
   PubMed Web of Science ®Google Scholar
• Antunes NT, Lamoureaux TL, Toth M, Stewart NK, Frase H, Vakulenko SB. Class D β-lactamases: are they all carbapenemases? Antimicrob Agents Chemother. 2014;2119–2125. doi:10.1128/AAC.02522-1324468778
   PubMed Web of Science ®Google Scholar
• Cockerill FR. Performance Standards for Antimicrobial Susceptibility Testing: Twenty-first Informational Supplement. Wayne, PA: CLSI; 2011.
   Google Scholar
• Englen M, Kelley L. A rapid DNA isolation procedure for the identification of Campylobacter jejuni by the polymerase chain reaction. Lett Appl Microbiol. 2000;31(6):421–426.11123549
   PubMed Web of Science ®Google Scholar
• Ocampo AM, Chen L, Cienfuegos AV, et al. High frequency of non-CG258 clones of carbapenem-resistant Klebsiella pneumoniae with distinct clinical characteristics: A two-year surveillance in five Colombian tertiary care hospitals. Antimicrob Agents Chemother. 2015;60(1):332–342. doi:10.1128/AAC.01775-1526503660
   PubMed Web of Science ®Google Scholar
• Khatun R, Shamsuzzaman S. Detection of OXA-181/OXA-48 carbapenemase producing Enterobacteriaceae in Bangladesh. IMC J Med Sci. 2015;9(2):45–51.
   Google Scholar
• Bassetti M, Peghin M, Vena A, Giacobbe DR. Treatment of infections due to MDR Gram-negative bacteria. Front Med. 2019;16. doi:10.3389/fmed.2019.00074.
   Web of Science ®Google Scholar
• Cheah S-E, Li J, Tsuji BT, Forrest A, Bulitta JB, Nation RL. Colistin and polymyxin B dosage regimens against Acinetobacter baumannii: differences in activity and the emergence of resistance. Antimicrob Agents Chemother. 2016;60(7):3921–3933. doi:10.1128/AAC.02927-1527067324
   PubMed Web of Science ®Google Scholar
• Elabd FM, Al-Ayed MS, Asaad AM, Alsareii SA, Qureshi MA, Musa H-A-A. Molecular characterization of oxacillinases among carbapenem-resistant Acinetobacter baumannii nosocomial isolates in a Saudi hospital. J Infect Public Health. 2015;8(3):242–247. doi:10.1016/j.jiph.2014.10.00225466594
   PubMed Web of Science ®Google Scholar
• Al-Agamy MH, Jeannot K, El-Mahdy TS, et al. First detection of GES-5 carbapenemase-producing Acinetobacter baumannii isolate. Microb Drug Resist. 2017;23(5):556–562. doi:10.1089/mdr.2016.015227854148
   PubMed Web of Science ®Google Scholar
• AlMasoudi SB, Aly M, AlHumidi NQ, Halwani MA. Incidence and prevalence of Acinetobacter baumannii in king fahd general hospital, Saudi Arabia. Life Sci J. 2013;10(4):1702–1710.
   Google Scholar
• Al-Agamy MH, Shibl AM, Ali MS, Khubnani H, Radwan HH, Livermore DM. Distribution of β-lactamases in carbapenem-non-susceptible Acinetobacter baumannii in Riyadh, Saudi Arabia. J Glob Antimicrob Resist. 2014;2(1):17–21. doi:10.1016/j.jgar.2013.08.00427873632
   PubMed Web of Science ®Google Scholar
• Abdalhamid B, Hassan H, Itbaileh A, Shorman M. Characterization of carbapenem-resistant Acinetobacter baumannii clinical isolates in a tertiary care hospital in Saudi Arabia. New Microbiol. 2014;37(1):65–73.24531172
   PubMed Web of Science ®Google Scholar
• Aljindan R, Bukharie H, Alomar A, Abdalhamid B. Prevalence of digestive tract colonization of carbapenem-resistant Acinetobacter baumannii in hospitals in Saudi Arabia. J Med Microbiol. 2015;64(4):400–406. doi:10.1099/jmm.0.00003325657302
   PubMed Web of Science ®Google Scholar
• El-Mahdy TS, Al-Agamy MH, Al-Qahtani AA, Shibl AM. Detection of bla OXA-23-like and bla NDM-1 in Acinetobacter baumannii from the Eastern Region, Saudi Arabia. Microb Drug Resist. 2017;23(1):115–121. doi:10.1089/mdr.2015.030427183378
   PubMed Web of Science ®Google Scholar
• Bennett P. Plasmid encoded antibiotic resistance: acquisition and transfer of antibiotic resistance genes in bacteria. Brit J Pharmacol. 2008;153(S1):S347–S357. doi:10.1038/sj.bjp.070760718193080
   PubMed Web of Science ®Google Scholar
• Perez-Llarena FJ, Bou G. β-Lactamase inhibitors: the story so far. Curr Med Chem. 2009;16(28):3740–3765. doi:10.2174/09298670978910495719747143
   PubMed Web of Science ®Google Scholar
• Wood GC, Scott DH, Martin AC, Timothy CF, Bradley AB. Comparison of ampicillin-sulbactam and imipenem-cilastatin for the treatment of Acinetobacter ventilator-associated pneumonia. Clin Infec Dis. 2002;34(11):1425–1430. doi:10.1086/34005512015687
   PubMed Web of Science ®Google Scholar
• Nowak J, Zander E, Stefanik D, et al. High incidence of pandrug-resistant Acinetobacter baumannii isolates collected from patients with ventilator-associated pneumonia in Greece, Italy and Spain as part of the MagicBullet clinical trial. J Antimicrob Chemother. 2017;72(12):3277–3282. doi:10.1093/jac/dkx32228961773
   PubMed Web of Science ®Google Scholar
• Leangapichart T, Gautret P, Griffiths K, et al. Acquisition of a high diversity of bacteria during the Hajj pilgrimage, including Acinetobacter baumannii with blaOXA-72 and Escherichia coli with blaNDM-5 carbapenemase genes. Antimicrob Agents Chemother. 2016;60(10):5942–5948. doi:10.1128/AAC.00669-1627458222
   PubMedGoogle Scholar
• Alsultan A, Evans B, Elsayed E, et al. High frequency of carbapenem-resistant Acinetobacter baumannii in patients with diabetes mellitus in Saudi Arabia. J Med Microbiol. 2013;62(6):885–888. doi:10.1099/jmm.0.057216-023518655
   PubMed Web of Science ®Google Scholar
• Al-Sultan AA, Evans BA, Aboulmagd E, et al. Dissemination of multiple carbapenem-resistant clones of Acinetobacter baumannii in the Eastern District of Saudi Arabia. Fronts Microbiol. 2015;6. doi:10.3389/fmicb.2015.00634.
   Web of Science ®Google Scholar
• Memish ZA, Assiri A, Almasri M, et al. Molecular characterization of carbapenemase production among Gram-negative bacteria in Saudi Arabia. Microb Drug Resist. 2015;21(3):307–314.25569024
   PubMed Web of Science ®Google Scholar
• Ibrahim ME. Prevalence of Acinetobacter baumannii in Saudi Arabia: risk factors, antimicrobial resistance patterns and mechanisms of carbapenem resistance. Ann Clin Microbiol Antimicrob. 2019;18(1). doi:10.1186/s12941-12018-10301-x
   Google Scholar
• Drawz SM, Bonomo RA. Three decades of β-lactamase inhibitors. Clin Microbiol Rev. 2010;23(1):160–201.20065329
   PubMed Web of Science ®Google Scholar
• Haseeb A, Faidah HS, Bakhsh AR, et al. Antimicrobial resistance among pilgrims: a retrospective study from two hospitals in Makkah, Saudi Arabia. Int J Infect Dis. 2016;47(2016):92–94.27312582
   PubMed Web of Science ®Google Scholar
• Jaidane N, Naas T, Oueslati S, et al. Whole-genome sequencing of NDM-1-producing ST85 Acinetobacter baumannii isolates from Tunisia. Inter J Antimicrob Agents. 2018;52(6):916–921.
   Web of Science ®Google Scholar
• Nordmann P, Poirel L, Walsh TR, Livermore DM. The emerging NDM carbapenemases. Trends Microbiol. 2011;19(12):588–595.22078325
   PubMed Web of Science ®Google Scholar
• Palzkill T. Metallo-β-lactamase structure and function. Ann N Y Acad Sci. 2013;1277(1):91–104.23163348
   PubMed Web of Science ®Google Scholar
• Alyamani EJ, Khiyami MA, Booq RY, Alnafjan BM, Altammami MA, Bahwerth FS. Molecular characterization of extended-spectrum beta-lactamases (ESBLs) produced by clinical isolates of Acinetobacter baumannii in Saudi Arabia. Ann Clin Microbiol Antimicrob. 2015;14(1):38.26290183
   PubMed Web of Science ®Google Scholar
• Bertrand X, Dowzicky MJ. Antimicrobial susceptibility among gram-negative isolates collected from intensive care units in North America, Europe, the Asia-Pacific Rim, Latin America, the Middle East, and Africa between 2004 and 2009 as part of the tigecycline evaluation and surveillance trial. Clin Therap. 2012;34(1):124–137.22154196
   PubMed Web of Science ®Google Scholar
• Zowawi HM. Antimicrobial resistance in Saudi Arabia: an urgent call for an immediate action. Sau Med J. 2016;37(9):935.
   Web of Science ®Google Scholar
• Perez F, Van Duin D. Carbapenem-resistant Enterobacteriaceae: a menace to our most vulnerable patients. Clev Clin J Med. 2013;80(4):225–233.
   PubMed Web of Science ®Google Scholar
• El-Badawy MF, Tawakol WM, El-Far SW, et al. Molecular identification of aminoglycoside-modifying enzymes and plasmid-mediated quinolone resistance genes among Klebsiella pneumoniae clinical isolates recovered from Egyptian patients. Int J Microbio. 2017;2017. doi:10.1155/2017/8050432.
   Google Scholar
• Balsalobre LC, Dropa M, Lincopan N, Mamizuka EM, Matté GR, Matté MH. Detection of metallo-β-lactamases encoding genes in environmental isolates of Aeromonas hydrophila and Aeromonas jandaei. Lett Appl Microbiol. 2009;49(1):142–145.19413767
   PubMed Web of Science ®Google Scholar
• Novovic K, Mihajlovic S, Vasiljevic Z, Filipic B, Begovic J, Jovcic B. Carbapenem-resistant Acinetobacter baumannii from Serbia: revision of CarO classification. PLoS One. 2015;10(3):e0122793.25822626
   PubMed Web of Science ®Google Scholar
• Tarashi S, Goudarzi H, Erfanimanesh S, Pormohammad A, Hashemi A. Phenotypic and molecular detection of Metallo-beta-lactamase genes among imipenem resistant Pseudomonas aeruginosa and Acinetobacter baumannii strains isolated from patients with burn injuries. Arch Clin Infect Dis. 2016;11(4). doi:10.5812/archcid.39036
   Google Scholar
• Qi C, Malczynski M, Parker M, Scheetz MH. Characterization of genetic diversity of carbapenem-resistant Acinetobacter baumannii clinical strains collected from 2004 to 2007. J Clin Microbiol. 2008;46(3):1106–1109.18216212
   PubMed Web of Science ®Google Scholar
• Woodford N, Ellington MJ, Coelho JM, et al. Multiplex PCR for genes encoding prevalent OXA carbapenemases in Acinetobacter spp. Int J Antimicrob Agents. 2006;27(4):351–353.16564159
   PubMed Web of Science ®Google Scholar
• van der Zwaluw K, de Haan A, Pluister GN, Bootsma HJ, de Neeling AJ, Schouls LM. The carbapenem inactivation method (CIM), a simple and low-cost alternative for the Carba NP test to assess phenotypic carbapenemase activity in Gram-negative rods. PLoS One. 2015;10(3):e0123690.25798828
   PubMed Web of Science ®Google Scholar
• Shamsizadeh Z, Nikaeen M, Esfahani BN, Mirhoseini SH, Hatamzadeh M, Hassanzadeh A. Detection of antibiotic resistant Acinetobacter baumannii in various hospital environments: potential sources for transmission of Acinetobacter infections. Environ Health Prev Med. 2017;22(1):22–44.29165130
   PubMed Web of Science ®Google Scholar